Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Graph

AMPH Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $183.90M; Cost of revenue $90.43M; Research and development $22.16M; Operating expenses $53.74M.
  • 2026-03-31: Revenue $171.17M; Cost of revenue $100.85M; Research and development $26.74M; Operating expenses $56.69M.
  • 2025-12-31: Revenue $183.10M*; Cost of revenue $97.44M*; Research and development $23.31M*; Operating expenses $50.06M*.
  • 2025-09-30: Revenue $191.84M; Cost of revenue $93.19M; Research and development $22.35M; Operating expenses $73.33M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AMPH revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.CN$4.56MFR$7.00MUS$172.34MRevenue$183.90MCost of revenue$90.43MGross profit$93.47MOperating expenses$53.74MOperating income$39.73MOther income, net$3.19MResearch & development$22.16MPre-tax income$38.54MIncome tax$8.20MNet income$30.35M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AMPH revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Finished PharmaceuticalProducts Segment$183.90MRevenue$183.90MCost of revenue$90.43MGross profit$93.47MOperating expenses$53.74MOperating income$39.73MOther income, net$3.19MResearch & development$22.16MPre-tax income$38.54MIncome tax$8.20MNet income$30.35M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$183.90M$90.43M$22.16M$53.74M$8.20M$30.35M
2026-03-31$171.17M$100.85M$26.74M$56.69M$3.63M$6.42M
2025-12-31$183.10M*$97.44M*$23.31M*$50.06M*$7.49M*$24.43M*
2025-09-30$191.84M$93.19M$22.35M$73.33M$4.16M$17.35M
2025-06-30$174.41M$87.92M$20.08M$44.31M$8.30M$31.03M
2025-03-31$170.53M$85.28M$20.10M$47.96M$5.58M$25.29M
2024-09-30$191.21M$89.27M$21.08M$44.89M$7.25M$40.43M
2024-06-30$182.39M$87.23M$17.65M$39.95M$12.29M$37.95M
2024-03-31$171.84M$81.74M$17.04M$42.09M$4.13M$43.18M
2023-09-30$180.56M$72.15M$16.66M$35.73M$14.03M$49.22M
2023-06-30$145.71M$72.97M$16.84M$35.84M$6.38M$26.12M
2023-03-31$140.02M$66.18M$19.82M$40.41M$6.75M$26.03M
2022-09-30$120.13M$61.62M$18.51M$35.28M$6.56M$15.87M
2022-06-30$123.47M$60.11M$22.80M$38.53M$5.55M$17.35M
2022-03-31$120.37M$64.54M$16.22M$34.21M$4.08M$24.25M
2021-09-30$112.20M$61.02M$10.76M$26.41M$6.69M$29.55M
2021-06-30$101.66M$54.29M$18.12M$36.82M$5.59M$7.77M
2021-03-31$103.02M$58.07M$14.77M$34.64M$1.16M$5.04M
2020-09-30$83.43M$46.92M$17.64M$32.99M$2.29M$3.92M
2020-06-30$85.81M$52.63M$16.15M$36.10M-$75.00K-$192.00K
2020-03-31$84.69M$47.87M$15.30M$29.34M$2.28M$3.95M
2019-12-31$83.38M(m)(m)(m)(m)-$1.03M
2019-09-30$80.14M$44.88M$18.61M$32.85M$598.00K$1.31M
2019-06-30$79.05M$46.66M$16.00M$31.41M$14.17M$47.79M
2019-03-31$79.79M$48.89M$14.61M$34.08M-$1.48M$868.00K
2018-12-31$89.69M(m)(m)(m)(m)$1.87M
2018-09-30$75.54M$46.28M$11.34M$26.71M$958.00K$2.39M
2018-06-30$71.04M$44.98M$15.46M$29.00M-$1.35M-$2.85M
2018-03-31$58.39M$41.42M$14.03M$26.75M-$1.75M-$7.14M
2017-12-31$60.40M(m)(m)(m)(m)$1.47M
2017-09-30$57.92M$37.36M$10.07M$23.50M-$2.21M$99.00K
2017-06-30$65.19M$38.44M$10.73M$24.56M$1.20M$1.97M
2017-03-31$56.67M$33.84M$11.25M$21.42M$611.00K$893.00K
2016-12-31$63.54M(m)(m)(m)(m)-$2.74M
2016-09-30$64.22M$36.61M$9.72M$21.82M$2.11M$3.89M
2016-06-30$68.03M$36.32M$10.59M$21.38M$2.86M$6.89M
2016-03-31$59.37M$34.46M$8.61M$20.83M$1.33M$2.49M
2015-12-31$76.91M(m)(m)(m)(m)$7.53M
2015-09-30$63.87M$46.29M$11.12M$21.33M-$1.27M-$3.01M
2015-06-30$53.85M$40.53M$10.73M$23.58M-$3.58M-$6.65M
2015-03-31$56.89M$43.61M$6.57M$20.54M-$5.53M-$665.00K
2014-12-31$55.88M(m)(m)(m)(m)-$2.52M
2014-09-30$59.71M$47.92M$8.59M$19.61M-$2.60M-$5.38M
2014-06-30$49.00M$34.01M$5.99M$16.17M-$696.00K-$1.18M
2014-03-31$45.87M$33.36M$6.21M$14.48M-$852.00K-$1.62M
2013-12-31$54.88M(m)(m)(m)(m)$1.83M
2013-09-30$59.32M$39.04M$9.04M$20.05M$494.00K-$160.00K
2013-06-30$62.52M$35.03M$7.79M$15.51M$4.11M$7.81M
2013-03-31$52.96M(m)(m)(m)(m)$2.38M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$355.07M$191.28M$48.90M$110.43M$11.83M$36.77M
2025-06-30$344.94M$173.20M$40.18M$92.26M$13.88M$56.31M
2024-06-30$354.23M$168.96M$34.70M$82.04M$16.42M$81.13M
2023-06-30$285.73M$139.16M$36.66M$76.25M$13.13M$52.16M
2022-06-30$243.84M$124.65M$39.02M$72.75M$9.63M$41.60M
2021-06-30$204.68M$112.36M$32.89M$71.46M$6.75M$12.81M
2020-06-30$170.49M$100.49M$31.45M$65.44M$2.21M$3.76M
2019-06-30$158.84M$95.55M$30.60M$65.49M$12.69M$48.66M
2018-06-30$129.43M$86.40M$29.49M$55.75M-$3.10M-$9.99M
2017-06-30$121.86M$72.28M$21.98M$45.99M$1.81M$2.87M
2016-06-30$127.40M$70.78M$19.20M$42.21M$4.18M$9.38M
2015-06-30$110.74M$84.14M$17.29M$44.12M-$9.11M-$7.31M
2014-06-30$94.87M$67.37M$12.20M$30.65M-$1.55M-$2.80M
2013-06-30$115.49M$68.44M$16.70M$32.71M$3.92M$10.19M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$536.78M$266.39M$62.53M$165.59M$18.05M$73.67M
2024-09-30$545.44M$258.24M$55.77M$126.93M$23.67M$121.56M
2023-09-30$466.29M$211.31M$53.32M$111.97M$27.16M$101.38M
2022-09-30$363.96M$186.27M$57.53M$108.03M$16.19M$57.47M
2021-09-30$316.88M$173.38M$43.65M$97.87M$13.44M$42.36M
2020-09-30$253.93M$147.42M$49.10M$98.43M$4.49M$7.68M
2019-09-30$238.97M$140.43M$49.21M$98.34M$13.29M$49.97M
2018-09-30$204.98M$132.68M$40.83M$82.46M-$2.14M-$7.61M
2017-09-30$179.77M$109.75M$32.12M$69.54M-$466.00K$2.86M
2016-09-30$191.62M$107.39M$28.92M$64.03M$6.29M$13.27M
2015-09-30$174.61M$130.43M$28.41M$65.44M-$10.38M-$10.32M
2014-09-30$154.58M$115.29M$20.79M$50.26M-$4.15M-$8.18M
2013-09-30$174.81M$107.48M$25.74M$52.77M$4.41M$10.03M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$719.89M$363.83M$85.84M$215.65M$25.53M$98.09M
2024-12-31$731.97M$358.11M$73.91M$168.44M$29.67M$159.52M
2023-12-31$644.39M$293.27M$73.74M$154.13M$31.83M$137.54M
2022-12-31$498.99M$250.13M$74.77M$141.36M$23.48M$91.39M
2021-12-31$437.77M$238.03M$60.93M$129.85M$20.63M$62.12M
2020-12-31$349.85M$206.51M$67.23M$132.39M$3.54M$1.40M
2019-12-31$322.36M$190.43M$68.85M$131.96M$13.72M$48.94M
2018-12-31$294.67M$187.68M$57.56M$115.61M-$3.27M-$5.74M
2017-12-31$240.18M$149.67M$43.50M$91.78M-$2.40M$3.65M
2016-12-31$255.16M$150.97M$41.52M$88.82M$4.81M$9.82M
2015-12-31$251.52M$174.17M$37.27M$84.25M-$7.58M-$2.79M
2014-12-31$210.46M$159.21M$28.87M$69.24M-$7.45M-$10.70M
2013-12-31$229.68M$142.72M$33.02M$69.47M$5.37M$11.86M
2012-12-31$204.32M$114.02M$31.16M$64.91M$7.78M$18.09M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87